Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy
Clinical trial NCT05489458 · UNKNOWN
Trial details
- NCT number
- NCT05489458
- Sponsor
- BUSQUETS, JULI
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-01
- Primary completion
- 2022-10-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.